| Financial Year |
March 31 2023 |
| Monetary Funds |
1,960,280,724.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
53,359,090.81 |
| Accounts Receivable |
205,956,737.49 |
| Advances to Suppliers |
20,554,416.74 |
| Other Receivables |
5,709,955.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
243,094,062.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,851,929.09 |
| Total Current Assets |
2,636,640,710.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
76,639,709.29 |
| Investment Properties |
31,091,741.29 |
| Fixed Assetes |
997,276,413.29 |
| Under-construction Projects |
12,696,296.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,226,022.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
33,714,211.63 |
| Other Non-Current Assets |
53,706,588.66 |
| Sub-Total of Non-Current Assets |
2,723,065,147.14 |
| Total Assets |
5,359,705,857.34 |
| Short-Term Loans |
59,911,198.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
107,160,621.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
55,822,757.39 |
| Taxes Payable |
18,649,643.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
475,544,343.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
419,803.88 |
| Other Current Liabilities |
1,819,159.03 |
| Sub-Total of Current Liabilities |
734,059,032.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,157,290.23 |
| Deferred Income Tax Liabilities |
161,998,321.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
211,538,350.78 |
| Total Liabilities |
945,597,383.38 |
| Paid-In Capital(Or Share Stock) |
183,992,992.00 |
| Capital Surplus |
1,711,511,268.23 |
| Surplus Reserve |
424,281,472.10 |
| LESS:Treasury Stock |
21,009,080.00 |
| Undistributed Profits |
1,190,456,124.55 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,414,108,473.96 |
| Owner's Equity（Stockholder's Equity） |
4,414,108,473.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,359,705,857.34 |
